Login to Your Account

Cellectis and Genomic Vision Receive €10M for HIV/Herpes

By James Etheridge

Wednesday, November 5, 2008

No Abstract


BioWorld International Correspondent

PARIS - Two French biotech firms, Cellectis SA and Genomic Vision SA, have launched a joint project for the development of a revolutionary treatment for HIV and herpes.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription